Implementation of the bethesda system for reporting thyroid cytopathology

Manon Auger, Ritu Nayar, Walid E. Khalbuss, Güliz A. Barkan, Cynthia C. Benedict, Rosemary Tambouret, Mary R. Schwartz, Lydia P Howell, Rhona J. Souers, David A. Hartley, Nicole Thomas, Ann T. Moriarty

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Context.-Although information about the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has been widely disseminated since its inception in 2007, the extent of its implementation and impact on daily practice has not been formally evaluated. Objectives.-To assess the extent of uptake of TBSRTC across pathology laboratories and to evaluate its impact on daily practice by collating participant responses to the 2011 supplemental thyroid questionnaire of the College of American Pathologists. Design.-A questionnaire was designed to gather information about various aspects of TBSRTC and mailed in June 2011 to 2063 laboratories participating in the College of American Pathologists cytopathology interlaboratory comparison program. The participating laboratories' answers were collated and summarized. Results.-Seven hundred and seventy-seven laboratories (37.6%) returned the survey. Although 60.9% (n = 451) and 17.1% (n = 127) of laboratories reported using TBSRTC or planning to use it in the near future, respectively, 22% (n = 163) had no plans to implement TBSRTC. Of the latter, 32% (n = 70) stated that they were unaware of this classification system. The majority (78.3%, n = 343) of the laboratories used TBSRTC as published in the Thyroid Bethesda System atlas, whereas 21.7% (n=95) used it with minor modifications. Most reported that the use of TBSRTC had caused either no change (n = 67, 15.2%) or only minor changes (n = 353, 80.2%) in the terminology and diagnostic criteria previously used in their laboratories. Conclusions.-According to the collected data, TBSRTC is generally well implemented in pathology laboratories. However, because approximately a third of those not using this terminology are not aware of it, additional educational efforts regarding TBSRTC are warranted.

Original languageEnglish (US)
Pages (from-to)1555-1559
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume137
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Thyroid Gland
Terminology
Pathology
Atlases
Information Systems

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Auger, M., Nayar, R., Khalbuss, W. E., Barkan, G. A., Benedict, C. C., Tambouret, R., ... Moriarty, A. T. (2013). Implementation of the bethesda system for reporting thyroid cytopathology. Archives of Pathology and Laboratory Medicine, 137(11), 1555-1559. https://doi.org/10.5858/arpa.2012-0658-CP

Implementation of the bethesda system for reporting thyroid cytopathology. / Auger, Manon; Nayar, Ritu; Khalbuss, Walid E.; Barkan, Güliz A.; Benedict, Cynthia C.; Tambouret, Rosemary; Schwartz, Mary R.; Howell, Lydia P; Souers, Rhona J.; Hartley, David A.; Thomas, Nicole; Moriarty, Ann T.

In: Archives of Pathology and Laboratory Medicine, Vol. 137, No. 11, 11.2013, p. 1555-1559.

Research output: Contribution to journalArticle

Auger, M, Nayar, R, Khalbuss, WE, Barkan, GA, Benedict, CC, Tambouret, R, Schwartz, MR, Howell, LP, Souers, RJ, Hartley, DA, Thomas, N & Moriarty, AT 2013, 'Implementation of the bethesda system for reporting thyroid cytopathology', Archives of Pathology and Laboratory Medicine, vol. 137, no. 11, pp. 1555-1559. https://doi.org/10.5858/arpa.2012-0658-CP
Auger M, Nayar R, Khalbuss WE, Barkan GA, Benedict CC, Tambouret R et al. Implementation of the bethesda system for reporting thyroid cytopathology. Archives of Pathology and Laboratory Medicine. 2013 Nov;137(11):1555-1559. https://doi.org/10.5858/arpa.2012-0658-CP
Auger, Manon ; Nayar, Ritu ; Khalbuss, Walid E. ; Barkan, Güliz A. ; Benedict, Cynthia C. ; Tambouret, Rosemary ; Schwartz, Mary R. ; Howell, Lydia P ; Souers, Rhona J. ; Hartley, David A. ; Thomas, Nicole ; Moriarty, Ann T. / Implementation of the bethesda system for reporting thyroid cytopathology. In: Archives of Pathology and Laboratory Medicine. 2013 ; Vol. 137, No. 11. pp. 1555-1559.
@article{c2269ddb41b4428d9fd724c29c70615b,
title = "Implementation of the bethesda system for reporting thyroid cytopathology",
abstract = "Context.-Although information about the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has been widely disseminated since its inception in 2007, the extent of its implementation and impact on daily practice has not been formally evaluated. Objectives.-To assess the extent of uptake of TBSRTC across pathology laboratories and to evaluate its impact on daily practice by collating participant responses to the 2011 supplemental thyroid questionnaire of the College of American Pathologists. Design.-A questionnaire was designed to gather information about various aspects of TBSRTC and mailed in June 2011 to 2063 laboratories participating in the College of American Pathologists cytopathology interlaboratory comparison program. The participating laboratories' answers were collated and summarized. Results.-Seven hundred and seventy-seven laboratories (37.6{\%}) returned the survey. Although 60.9{\%} (n = 451) and 17.1{\%} (n = 127) of laboratories reported using TBSRTC or planning to use it in the near future, respectively, 22{\%} (n = 163) had no plans to implement TBSRTC. Of the latter, 32{\%} (n = 70) stated that they were unaware of this classification system. The majority (78.3{\%}, n = 343) of the laboratories used TBSRTC as published in the Thyroid Bethesda System atlas, whereas 21.7{\%} (n=95) used it with minor modifications. Most reported that the use of TBSRTC had caused either no change (n = 67, 15.2{\%}) or only minor changes (n = 353, 80.2{\%}) in the terminology and diagnostic criteria previously used in their laboratories. Conclusions.-According to the collected data, TBSRTC is generally well implemented in pathology laboratories. However, because approximately a third of those not using this terminology are not aware of it, additional educational efforts regarding TBSRTC are warranted.",
author = "Manon Auger and Ritu Nayar and Khalbuss, {Walid E.} and Barkan, {G{\"u}liz A.} and Benedict, {Cynthia C.} and Rosemary Tambouret and Schwartz, {Mary R.} and Howell, {Lydia P} and Souers, {Rhona J.} and Hartley, {David A.} and Nicole Thomas and Moriarty, {Ann T.}",
year = "2013",
month = "11",
doi = "10.5858/arpa.2012-0658-CP",
language = "English (US)",
volume = "137",
pages = "1555--1559",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - Implementation of the bethesda system for reporting thyroid cytopathology

AU - Auger, Manon

AU - Nayar, Ritu

AU - Khalbuss, Walid E.

AU - Barkan, Güliz A.

AU - Benedict, Cynthia C.

AU - Tambouret, Rosemary

AU - Schwartz, Mary R.

AU - Howell, Lydia P

AU - Souers, Rhona J.

AU - Hartley, David A.

AU - Thomas, Nicole

AU - Moriarty, Ann T.

PY - 2013/11

Y1 - 2013/11

N2 - Context.-Although information about the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has been widely disseminated since its inception in 2007, the extent of its implementation and impact on daily practice has not been formally evaluated. Objectives.-To assess the extent of uptake of TBSRTC across pathology laboratories and to evaluate its impact on daily practice by collating participant responses to the 2011 supplemental thyroid questionnaire of the College of American Pathologists. Design.-A questionnaire was designed to gather information about various aspects of TBSRTC and mailed in June 2011 to 2063 laboratories participating in the College of American Pathologists cytopathology interlaboratory comparison program. The participating laboratories' answers were collated and summarized. Results.-Seven hundred and seventy-seven laboratories (37.6%) returned the survey. Although 60.9% (n = 451) and 17.1% (n = 127) of laboratories reported using TBSRTC or planning to use it in the near future, respectively, 22% (n = 163) had no plans to implement TBSRTC. Of the latter, 32% (n = 70) stated that they were unaware of this classification system. The majority (78.3%, n = 343) of the laboratories used TBSRTC as published in the Thyroid Bethesda System atlas, whereas 21.7% (n=95) used it with minor modifications. Most reported that the use of TBSRTC had caused either no change (n = 67, 15.2%) or only minor changes (n = 353, 80.2%) in the terminology and diagnostic criteria previously used in their laboratories. Conclusions.-According to the collected data, TBSRTC is generally well implemented in pathology laboratories. However, because approximately a third of those not using this terminology are not aware of it, additional educational efforts regarding TBSRTC are warranted.

AB - Context.-Although information about the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has been widely disseminated since its inception in 2007, the extent of its implementation and impact on daily practice has not been formally evaluated. Objectives.-To assess the extent of uptake of TBSRTC across pathology laboratories and to evaluate its impact on daily practice by collating participant responses to the 2011 supplemental thyroid questionnaire of the College of American Pathologists. Design.-A questionnaire was designed to gather information about various aspects of TBSRTC and mailed in June 2011 to 2063 laboratories participating in the College of American Pathologists cytopathology interlaboratory comparison program. The participating laboratories' answers were collated and summarized. Results.-Seven hundred and seventy-seven laboratories (37.6%) returned the survey. Although 60.9% (n = 451) and 17.1% (n = 127) of laboratories reported using TBSRTC or planning to use it in the near future, respectively, 22% (n = 163) had no plans to implement TBSRTC. Of the latter, 32% (n = 70) stated that they were unaware of this classification system. The majority (78.3%, n = 343) of the laboratories used TBSRTC as published in the Thyroid Bethesda System atlas, whereas 21.7% (n=95) used it with minor modifications. Most reported that the use of TBSRTC had caused either no change (n = 67, 15.2%) or only minor changes (n = 353, 80.2%) in the terminology and diagnostic criteria previously used in their laboratories. Conclusions.-According to the collected data, TBSRTC is generally well implemented in pathology laboratories. However, because approximately a third of those not using this terminology are not aware of it, additional educational efforts regarding TBSRTC are warranted.

UR - http://www.scopus.com/inward/record.url?scp=84887852094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887852094&partnerID=8YFLogxK

U2 - 10.5858/arpa.2012-0658-CP

DO - 10.5858/arpa.2012-0658-CP

M3 - Article

VL - 137

SP - 1555

EP - 1559

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -